Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

SIRT2 antibody

SIRT2 Reactivity: Human WB, ELISA Host: Mouse Monoclonal S2R233-1 unconjugated
Catalog No. ABIN1169092
  • Target See all SIRT2 Antibodies
    SIRT2 (Sirtuin 2 (SIRT2))
    Reactivity
    • 59
    • 42
    • 38
    • 8
    • 4
    • 4
    • 4
    • 3
    • 3
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Human
    Host
    • 58
    • 9
    • 1
    Mouse
    Clonality
    • 50
    • 18
    Monoclonal
    Conjugate
    • 44
    • 7
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    This SIRT2 antibody is un-conjugated
    Application
    • 47
    • 18
    • 14
    • 12
    • 11
    • 9
    • 5
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    Western Blotting (WB), ELISA
    Specificity
    Recognizes human sirtuin 2. Detects a band of ~45 kDa by Western blot.
    Cross-Reactivity
    Human
    Sterility
    0.2 μm filtered
    Immunogen
    Recombinant human sirtuin 2.
    Clone
    S2R233-1
    Isotype
    IgG2b
    Top Product
    Discover our top product SIRT2 Primary Antibody
  • Application Notes
    Optimal working dilution should be determined by the investigator.
    Restrictions
    For Research Use only
  • Format
    Liquid
    Concentration
    Lot specific
    Buffer
    0.2μm-filtered solution in PBS, pH 7.4. Contains no preservatives.
    Preservative
    Without preservative
    Storage
    4 °C,-20 °C
    Storage Comment
    Short Term Storage: +4°C
    Long Term Storage: -20°C
    Stable for at least 1 year after receipt when stored at -20°C.
    Expiry Date
    12 months
  • Target
    SIRT2 (Sirtuin 2 (SIRT2))
    Alternative Name
    Sirtuin 2 (SIRT2 Products)
    Background
    Sirtuin-2 is a NAD-dependent protein deacetylase, which deacetylates the 'Lys-40' of a-tubulin. It is involved in the control of mitotic exit in the cell cycle. Furthermore, a variety of age-associated diseases such as type 2 diabetes, obesity, osteoporosis, and Alzheimer's disease are associated with sirtuins. Selective inhibition of Sirtuin-2 achieves neuroprotection and identifies Sirtuin-2 to be a potential therapeutic avenue in Huntington's and Parkinson's disease.
    UniProt
    Q8IXJ6
You are here:
Support